| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/20/2000 | WO2000041548A2 Methods for glucagon suppression |
| 07/20/2000 | WO2000041546A2 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | WO2000041539A2 Human beta-1,3-galactosyltransferase homolog, znssp6 |
| 07/20/2000 | WO2000041537A2 Use of desert hedgehog protein |
| 07/20/2000 | WO2000041514A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 07/20/2000 | WO2000041508A2 Combination therapy of cancer by the activation of co-stimulatory molecules expressed by immune cells and cytokines |
| 07/20/2000 | WO2000041497A2 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 07/20/2000 | WO2000041484A2 Novel use of phospholipids of vegetable and animal origin in nutritional therapy |
| 07/20/2000 | WO2000041474A2 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | WO2000041463A2 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | WO2000028031A8 Mitogenic regulators |
| 07/20/2000 | WO2000026230A8 Low allergenic protein variants |
| 07/20/2000 | WO2000023591A3 Secreted protein zsig49 |
| 07/20/2000 | WO2000021981A3 TNFα BINDING PEPTIDES AND THEIR UTILIZATION FOR DETECTING, DEACTIVATING AND/OR REMOVING TNFα FROM BIOLOGICAL FLUIDS |
| 07/20/2000 | WO2000021979A3 Cyclic tetrapeptide and their use as histone deacetylase inhibitor |
| 07/20/2000 | WO2000021506A3 Pharmaceutical composition of glutathione modulators with antimony and/or arsenic for cancer therapy |
| 07/20/2000 | WO2000020590A3 G-protein coupled receptor proteins |
| 07/20/2000 | WO2000020589A3 PTANs: TESTIS SPECIFIC PROTEINS EXPRESSED IN PROSTATE CANCER |
| 07/20/2000 | WO2000020586A3 Renal cancer associated antigens and uses therefor |
| 07/20/2000 | WO2000020582A3 Gene replacement therapy for muscular dystrophy |
| 07/20/2000 | WO2000020572A3 Tissue binding peptides, identification, production and utilization thereof |
| 07/20/2000 | WO2000020041A3 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 07/20/2000 | WO2000020018A8 Kappa-a conopeptides and uses therefor |
| 07/20/2000 | WO2000018418A3 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 07/20/2000 | WO2000017358A3 Human chaperone proteins |
| 07/20/2000 | WO2000016800A3 Methods of treating chronic pain |
| 07/20/2000 | WO2000016758A3 Treatment of infection |
| 07/20/2000 | WO2000015783A3 ANTISENSE OLIGONUCLEOTIDE COMPOSITIONS TARGETED TO β1-ADRENOCEPTOR-SPECIFIC mRNA AND METHODS OF USE |
| 07/20/2000 | WO2000015767A3 Antigen-presenting cells and their use in therapy |
| 07/20/2000 | WO2000015660A8 Target of rnaiii activating protein (trap) |
| 07/20/2000 | WO2000015250A3 Fibroblast inhibitor |
| 07/20/2000 | WO2000015246A3 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 07/20/2000 | WO2000010598B1 Recombinant botulinium toxin for the treatment of mucus hypersecretion |
| 07/20/2000 | WO2000004917A3 USE OF HC gp-39 IN IMMUNE DISEASES |
| 07/20/2000 | WO2000004149A3 Compositions and methods for therapy and diagnosis of prostate cancer |
| 07/20/2000 | WO2000002902A9 Novel inhibitors of angiogenesis and tumor growth |
| 07/20/2000 | WO2000002897A9 Delta cleavage products and methods based thereon |
| 07/20/2000 | WO1999064048A9 Inhibitors of hiv reverse transcriptase |
| 07/20/2000 | WO1999063094A9 Nucleotide and protein sequences of gpr1 and methods based thereon |
| 07/20/2000 | WO1999056797A9 Fully recombinant tissue sealant compositions |
| 07/20/2000 | WO1999054353A3 Human nucleic acid sequences of normal uterus tissue |
| 07/20/2000 | DE19901009A1 Peptide zur Inhibierung von HBV-Core-Proteinen Peptides to inhibit HBV core proteins |
| 07/20/2000 | DE19901008A1 Peptide zur Inhibierung von HPV E6-Proteinen Peptides for inhibition of HPV-E6 proteins |
| 07/20/2000 | DE19855013A1 Androgen- und Progesteron-Rezeptor bindendes Hormon Response Element Androgen and progesterone receptor binding hormone response element |
| 07/20/2000 | DE19826628C1 Treatment of cerebral insufficiency by intranasal administration of insulin or analog, improves cerebral performance without affecting blood sugar levels |
| 07/20/2000 | CA2697598A1 Compounds and methods to inhibit or augment an inflammatory response |
| 07/20/2000 | CA2361204A1 Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses |
| 07/20/2000 | CA2360588A1 Human homologues of proteins regulated by circadian rhythms |
| 07/20/2000 | CA2360584A1 Mammalian alpha-helical protein - 12 |
| 07/20/2000 | CA2360563A1 Novel interferon-.alpha. |
| 07/20/2000 | CA2360464A1 Human peptidases |
| 07/20/2000 | CA2360387A1 Catalytic molecules |
| 07/20/2000 | CA2359980A1 Derivatives of monosaccharides as cell adhesion inhibitors |
| 07/20/2000 | CA2359492A1 Neisseria meningitidis antigen |
| 07/20/2000 | CA2359479A1 Novel complex-forming proteins |
| 07/20/2000 | CA2359474A1 Particles for oral delivery of peptides and proteins |
| 07/20/2000 | CA2359461A1 Inhibiting development of microvessels within vascular walls |
| 07/20/2000 | CA2359392A1 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
| 07/20/2000 | CA2359365A1 Anti-cd3 immunotoxins and therapeutic uses therefor |
| 07/20/2000 | CA2359345A1 Methods for making proteins containing free cysteine residues |
| 07/20/2000 | CA2359132A1 Bone marrow-specific protein |
| 07/20/2000 | CA2359110A1 Combination of hepatitis b vaccine with antiviral agents |
| 07/20/2000 | CA2359067A1 Polypeptide variants with altered effector function |
| 07/20/2000 | CA2358908A1 Bone stimulating factor |
| 07/20/2000 | CA2358804A1 Human beta-1,3-galactosyltransferase homolog, znssp6 |
| 07/20/2000 | CA2358684A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 07/20/2000 | CA2357726A1 Chorionic gonadotropin dna vaccines and methods |
| 07/20/2000 | CA2356990A1 Composition and method for improving function of embryonic kidney transplants |
| 07/20/2000 | CA2356939A1 Modulation of systemic memory t cell trafficking |
| 07/20/2000 | CA2356706A1 Novel exendin agonist formulations and methods of administration thereof |
| 07/20/2000 | CA2356611A1 New use of melagatran |
| 07/20/2000 | CA2355792A1 New amidinobenzylamine derivatives and their use as thrombin inhibitors |
| 07/20/2000 | CA2353088A1 Bis-amino acid sulfonamides containing n-terminally a substituted benzyl group as hiv protease inhibitors |
| 07/20/2000 | CA2325359A1 Novel lrsg protein and nucleic acid molecules and uses therefor |
| 07/19/2000 | EP1020529A2 Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells |
| 07/19/2000 | EP1020528A2 Method for producing secreted proteins |
| 07/19/2000 | EP1020522A1 Natural human antibody |
| 07/19/2000 | EP1020520A1 Prevention of immune related removal of cells from the mammalian body, mutant PML molecules useful therefor |
| 07/19/2000 | EP1020516A2 Leptospira vaccine antigens for the prevention of leptospirosis |
| 07/19/2000 | EP1020179A2 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 07/19/2000 | EP1019728A1 Method of activating a novel ligand regulatory pathway |
| 07/19/2000 | EP1019535A2 Highly sensitive multimeric nucleic acid probes |
| 07/19/2000 | EP1019529A1 A method of treating cancer |
| 07/19/2000 | EP1019522A1 Compositions and methods for administering pneumococcal dna |
| 07/19/2000 | EP1019518A1 Self-deleting vectors for cancer therapy |
| 07/19/2000 | EP1019515A1 Fusion proteins comprising an angiostatin moiety and their use in anti-tumour treatment |
| 07/19/2000 | EP1019514A1 A keratinocyte derived protease |
| 07/19/2000 | EP1019511A2 STABILIZATION OF ENVELOPE GLYCOPROTEIN TRIMERS BY DISULFIDE BONDS INTRODUCED INTO A gp41 GLYCOPROTEIN ECTODOMAIN |
| 07/19/2000 | EP1019510A1 Porcine circoviruses, vaccines and diagnostic reagents |
| 07/19/2000 | EP1019507A1 Amino-terminally truncated rantes as chemokine antagonists |
| 07/19/2000 | EP1019506A1 101 human secreted proteins |
| 07/19/2000 | EP1019505A1 Human hox c10 and polynucleotides encoding |
| 07/19/2000 | EP1019503A1 Tango-71, tango-73, tango-74, tango-76, and tango-83 nucleic acid molecules and polypeptides |
| 07/19/2000 | EP1019500A2 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons |
| 07/19/2000 | EP1019497A1 Hammerhead ribozymes with extended cleavage rule |
| 07/19/2000 | EP1019490A2 Methods for modulating hematopoiesis and vascular growth |
| 07/19/2000 | EP1019442A1 Gamma-1 and gamma-3 anti-human cd23 monoclonal antibodies and use thereof as therapeutics |
| 07/19/2000 | EP1019439A1 Soluble single-chain t-cell receptor proteins |
| 07/19/2000 | EP1019438A1 Apoptosis-related compounds and their use |
| 07/19/2000 | EP1019437A1 Method for the covalent attachment of polysaccharides to protein molecules |